Dr. Martens plc (LON:DOCS)
London · Delayed Price · Currency is GBP · Price in GBX 86.20
+2.40 (2.86%)
Aug 11, 2026, 4:47 PM GMT
Dr. Martens Cash Flow Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 23.8 | 4.5 | 69.2 | 128.9 | 181.2 |
Depreciation & Amortization | 72.6 | 76.8 | 72.3 | 58.1 | 36.9 |
Stock-Based Compensation | 5.2 | 7.2 | 4 | 0.5 | 5.2 |
Other Adjustments | 33.5 | 31.9 | 54.5 | 58 | 44.9 |
Change in Receivables | -8.8 | 6.3 | 23 | -6.6 | -23.3 |
Changes in Inventories | 23.5 | 62.7 | -1.6 | -133.2 | -18.3 |
Changes in Accounts Payable | 5.1 | 15.3 | -36.2 | -9.2 | -1 |
Changes in Income Taxes Payable | -10.9 | -12.2 | -18.8 | -22.3 | -41.2 |
Changes in Other Operating Activities | -1.3 | 3.8 | 1.5 | -1.5 | - |
Operating Cash Flow | 142.7 | 196.3 | 167.9 | 72.7 | 184.4 |
Operating Cash Flow Growth | -27.30% | 16.91% | 130.95% | -60.58% | 16.05% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -9.2 | -8.4 | -18.2 | -39.6 | -15.5 |
Purchases of Intangible Assets | -2.7 | -10.3 | -10.2 | -11.8 | -9.5 |
Purchases of Investments | - | - | - | -1 | - |
Other Investing Activities | 3.7 | 3.4 | 2.9 | 1.8 | - |
Investing Cash Flow | -8.2 | -15.3 | -25.5 | -50.6 | -25 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | - | 30 | - | - |
Short-Term Debt Repaid | - | - | -30 | - | - |
Long-Term Debt Issued | - | 250 | - | - | - |
Long-Term Debt Repaid | -49.3 | -332.3 | -43.6 | -29.1 | -20.5 |
Net Long-Term Debt Issued (Repaid) | -49.3 | -82.3 | -43.6 | -29.1 | -20.5 |
Repurchase of Common Stock | -6.7 | - | -50.5 | - | - |
Net Common Stock Issued (Repurchased) | -6.7 | - | -50.5 | - | - |
Common Dividends Paid | -24.6 | -9.5 | -57.8 | -58.4 | -12.2 |
Other Financing Activities | -27.2 | -42.4 | -34 | -7.4 | -14.3 |
Financing Cash Flow | -107.8 | -134.2 | -185.9 | -94.9 | -47 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | -2.3 | -2 | -2.9 | 2.3 | 2 |
Net Cash Flow | 26.7 | 46.8 | -43.5 | -72.8 | 112.4 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 133.5 | 187.9 | 149.7 | 33.1 | 168.9 |
Free Cash Flow Growth | -28.95% | 25.52% | 352.27% | -80.40% | 13.74% |
FCF Margin | 17.45% | 23.86% | 17.07% | 3.31% | 18.60% |
Free Cash Flow Per Share | 0.14 | 0.19 | 0.15 | 0.03 | 0.17 |
Levered Free Cash Flow | 54.3 | 60.2 | 24.6 | -47.9 | 121.6 |
Unlevered Free Cash Flow | 121.29 | 156.92 | 89.93 | -43.54 | 120.88 |